Alan Hambelton

Partner
Full contact info

I love working with innovative companies that are defining the future of technology and medicine.

Experience

Zillow Agrees to Acquire Follow Up Boss

November 1, 2023

Cooley advised Zillow Group, a company reimagining real estate to make home a reality for more people, on its definitive agreement to acquire Follow Up Boss, a customer relationship management system for real estate professionals, for $400 million in initial cash consideration and up to $100 million in a potential cash earnout.

Read more

Related contacts

Nick Davis
Partner, Seattle
Alan Hambelton
Partner, Seattle
Barbara Mirza
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Michael Egan
Partner, Washington DC
Robert M. McDowell
Partner, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
Eileen Leman
Associate, Los Angeles Downtown
Tyler McClure
Associate, San Francisco
Gary Warren Hunt III
Associate, Washington DC
Austin Holt
Associate, Los Angeles Santa Monica
Carly E. Gibbons
Associate, Chicago
Megan Drill
Associate, San Diego
Cristina DeBiase
Associate, Boston
Eileen Marshall
Partner, Washington DC
Calvin Lee
Associate, New York

Related Practices & Industries

Dutch Bros Announces $300 Million Underwritten Public Offering

September 6, 2023

Cooley advised Dutch Bros, a publicly held drive-thru coffee chain, on its $300 million underwritten public offering of Class A common stock.

Read more

Related contacts

Eric Jensen
Partner, Palo Alto
Alan Hambelton
Partner, Seattle
Julia Stark
Associate, Seattle
Allison Peth
Associate, Palo Alto
Ben Lima
Associate, Palo Alto
Reza Safai
Associate, Palo Alto
Patrick Gibbs
Partner, Palo Alto

Related Practices & Industries

Cytokinetics – $450 Million Convertible Senior Notes Offering

July 8, 2022

Cooley advised biopharmaceutical company Cytokinetics on its Rule 144A offering of $450 million aggregate principal amount of 3.50% convertible senior notes due in 2027, which includes the full exercise of the initial purchasers’ option to purchase an additional $90 million aggregate principal amount of notes. Lawyers Robert Jones, Mischi a Marca, Alan Hambelton, Jason Savich, Julia Stark, Justine Chiu and Hailey Yook led the Cooley team advising Cytokinetics.

Read more

Related contacts

Robert L. Jones
Partner, Palo Alto
Mischi a Marca
Partner, San Francisco
Alan Hambelton
Partner, Seattle
Jason Savich
Partner, San Francisco
Xander Lee
Partner, Los Angeles Santa Monica
Eileen Marshall
Partner, Washington DC
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington DC
Julia Stark
Associate, Seattle
Hailey Yook
Associate, San Francisco

Related Practices & Industries

Dutch Bros – $556.8 Million IPO

September 24, 2021

Cooley advised Dutch Bros, a drive-thru coffeehouse chain, on its $556.8 million initial public offering of 24,210,526 shares of its common stock. Partners Eric Jensen, Alan Hambelton and Dave Peinsipp led the Cooley team advising Dutch Bros.

Read more

Related contacts

Eric Jensen
Partner, Palo Alto
Alan Hambelton
Partner, Seattle
David Peinsipp
Partner, San Francisco
Julia Stark
Associate, Seattle
Allison Peth
Associate, Palo Alto
Reza Safai
Associate, Palo Alto
Todd Gluth
Partner, San Diego
Stephanie Gentile
Partner, New York
Timothy Shapiro
Partner, Palo Alto
Alessandra Murata
Partner, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
David Navetta
Partner, Colorado
Ehijele Olumese
Associate, Los Angeles Downtown
Wendy Brenner
Partner, Palo Alto
Amis Pan
Associate, Palo Alto
Charlie Kim
Partner, San Diego
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Eliem Therapeutics – $92 Million IPO

August 10, 2021

Cooley advised Eliem Therapeutics on its $92 million initial public offering of 7,360,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Eliem Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol ELYM, is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Partners Alan Hambelton, Sonya Erickson and Stephen Rosen led the Cooley team.

Related contacts

Alan Hambelton
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Stephen Rosen
Partner, London
Julia Stark
Associate, Seattle
Willy Cowles
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle

Related Practices & Industries

View more

Memberships & affiliations

Washington State Bar Association